{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:52:37Z","timestamp":1787727157522,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jfo.2022.11.022","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:16:41Z","timestamp":1682194601000},"page":"622-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of systemic IL-6 trans-signalling in patients with primary open-angle glaucoma"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2659-1940","authenticated-orcid":false,"given":"Z.S.","family":"Ulhaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-3935","authenticated-orcid":false,"given":"L.A.","family":"Istifiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-3536","authenticated-orcid":false,"given":"S.A.","family":"Pamungkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2022.11.022_bib0195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.oftal.2020.03.018","article-title":"Aqueous humor interleukin-6 levels in primary open-angle glaucoma (POAG): a systematic review and meta-analysis","volume":"95","author":"Ulhaq","year":"2020","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.oftal.2019.11.014","article-title":"Chemokine IL-8 level in aqueous humor of open-angle glaucoma: a meta-analysis","volume":"95","author":"Ulhaq","year":"2020","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0205","article-title":"Vitamin D and its receptor polymorphisms are associated with glaucoma","author":"Ulhaq","year":"2020431009","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43088-020-0034-8","article-title":"The association of estrogen-signaling pathways and susceptibility to open-angle glaucoma","volume":"9","author":"Ulhaq","year":"2020","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0215","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3892\/mmr.2020.11215","article-title":"Primary open angle glaucoma genetics: the common variants and their clinical associations","volume":"22","author":"Trivli","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jfo.2022.11.022_bib0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00417-019-04239-9","article-title":"Is primary open-angle glaucoma an ocular manifestation of systemic disease?","volume":"257","author":"Wey","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jnr.24256","article-title":"Neuroimmflammation and microglia in glaucoma\u00a0\u2013\u00a0time for a paradigm shift","volume":"97","author":"Wei","year":"2019","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jfo.2022.11.022_bib0230","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IJG.0b013e3181b4cac7","article-title":"Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma","volume":"19","author":"Huang","year":"2010","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2022.11.022_bib0235","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/OPTH.S162999","article-title":"Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma","volume":"12","author":"Kondkar","year":"2018","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.jfo.2022.11.022_bib0240","first-page":"123","article-title":"Interleukin-6 participation in pathology of ocular diseases","volume":"24","author":"Zahir-Jouzdani","year":"2017","journal-title":"Pathophysiol Off J Int Soc Pathophysiol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0245","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1038\/s41598-020-74203-9","article-title":"The role of IL-6-174 G\/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis","volume":"10","author":"Ulhaq","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfo.2022.11.022_bib0250","article-title":"Serum IL-6\/IL-10 ratio as a biomarker for the diagnosis and severity assessment of primary-open angle glaucoma","author":"Ulhaq","year":"2022322259","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/17469899.2021.1990758","article-title":"Association between serum interleukin-6 levels with the risk and clinical severity of primary open-angle glaucoma","volume":"16","author":"Ulhaq","year":"2021","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0260","first-page":"1005","article-title":"Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy","volume":"22","author":"Chen","year":"2016","journal-title":"Mol Vis"},{"key":"10.1016\/j.jfo.2022.11.022_bib0265","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1167\/iovs.08-1953","article-title":"Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor","volume":"49","author":"Simon","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","article-title":"Interleukin-6 in aging and chronic disease: a magnificent pathway","volume":"61","author":"Maggio","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0275","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1074\/jbc.RA118.003298","article-title":"Interleukin-6-mediated trans-signaling inhibits transforming growth factor-\u03b2 signaling in trabecular meshwork cells","volume":"293","author":"Inoue-Mochita","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfo.2022.11.022_bib0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.61.13.29","article-title":"Lysophosphatidic acid and IL-6 trans-signaling interact via YAP\/TAZ and STAT3 signaling pathways in human trabecular meshwork cells","volume":"61","author":"Yemanyi","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0285","first-page":"326","article-title":"Cross-talk between TGF-\u03b21 and IL-6 in human trabecular meshwork cells","volume":"15","author":"Liton","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.jfo.2022.11.022_bib0290","first-page":"6585","article-title":"Soluble IL-6R and neuroprotection of retinal ganglion cells in glaucoma","volume":"53","author":"Cathcart","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0295","doi-asserted-by":"crossref","first-page":"e24288","DOI":"10.1002\/jcla.24288","article-title":"Comparative performance of ELISA and dot blot assay for TSH-receptor antibody detection in Graves\u2019 disease","volume":"36","author":"Zulkarnain","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jfo.2022.11.022_bib0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.medcli.2020.05.017","article-title":"Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis","volume":"155","author":"Soraya","year":"2020","journal-title":"Med Clin Engl Ed"},{"key":"10.1016\/j.jfo.2022.11.022_bib0305","doi-asserted-by":"crossref","first-page":"100075","DOI":"10.1016\/j.deman.2022.100075","article-title":"The retinal nerve fiber layer thickness is useful for the assessment of diabetic retinopathy severity","author":"Ulhaq","year":"2022","journal-title":"Diabetes Epidemiol Manag"},{"key":"10.1016\/j.jfo.2022.11.022_bib0310","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1074\/jbc.RA117.001163","article-title":"The balance of interleukin (IL)-6, IL-6\u00b7soluble IL-6 receptor (sIL-6R), and IL-6\u00b7sIL-6R\u00b7sgp130 complexes allows simultaneous classic and trans-signaling","volume":"293","author":"Baran","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfo.2022.11.022_bib0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2018.09.009","article-title":"Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells","volume":"178","author":"Valle","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2022.11.022_bib0320","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1073\/pnas.0501794102","article-title":"IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation","volume":"102","author":"McLoughlin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jfo.2022.11.022_bib0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2007.07.184","article-title":"Regulation of a lymphocyte\u00a0\u2013\u00a0endothelial\u00a0\u2013\u00a0IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance","volume":"39","author":"Vardam","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.jfo.2022.11.022_bib0330","doi-asserted-by":"crossref","first-page":"101574","DOI":"10.1016\/j.redox.2020.101574","article-title":"Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy","volume":"34","author":"Robinson","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0335","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1038\/s41598-020-74203-9","article-title":"The role of IL-6-174 G\/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis","volume":"10","author":"Ulhaq","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfo.2022.11.022_bib0340","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1177\/1120672120940198","article-title":"Association of interleukin-6 gene polymorphisms and glaucoma: systematic review and meta-analysis","volume":"31","author":"Wu","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.11.022_bib0345","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.oftal.2021.11.003","article-title":"The rs1800795 single nucleotide polymorphism in the IL6 gene is not associated with primary open angle glaucoma in Mexican population","volume":"97","author":"Ponce-Gallegos","year":"2022","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"10.1016\/j.jfo.2022.11.022_bib0350","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1167\/iovs.08-1953","article-title":"Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor","volume":"49","author":"Simon","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0355","first-page":"786","article-title":"Cleavage of IL-6 receptor alpha as a potential mechanism for IL-6 transsignaling in glaucoma","volume":"54","author":"Russom","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.11.022_bib0360","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","article-title":"Interleukin-6, its role in fibrosing conditions","volume":"23","author":"O\u2019Reilly","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jfo.2022.11.022_bib0365","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.189.3.599","article-title":"C-reactive protein: a physiological activator of interleukin 6 receptor shedding","volume":"189","author":"Jones","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfo.2022.11.022_bib0370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/eye.2016.234","article-title":"Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration","volume":"31","author":"Fischer","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2022.11.022_bib0375","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbrc.2012.12.004","article-title":"IL-6 treatment increases the survival of retinal ganglion cells in vitro: the role of adenosine A1 receptor","volume":"430","author":"Per\u00edgolo-Vicente","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jfo.2022.11.022_bib0380","doi-asserted-by":"crossref","first-page":"103141","DOI":"10.1016\/j.isci.2021.103141","article-title":"Interleukin-6 promotes microtubule stability in axons via Stat3 protein\u2013protein interactions","volume":"24","author":"Wareham","year":"2021","journal-title":"IScience"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:20:08Z","timestamp":1759260008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551223001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0181551223001432"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2022.11.022","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of systemic IL-6 trans-signalling in patients with primary open-angle glaucoma","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2022.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}